おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Karus Therapeutics
company
About
Karus is a pharmaceutical company focused on the design and development of molecular-targeted, small molecule drugs to treat cancer.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- £1M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
£1M
Karus Therapeutics has raised a total of
£1M
in funding over 2 rounds. Their latest funding was raised on
Apr 6, 2009 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2009 | Series Unknown | £1M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Karus Therapeutics is funded by 1 investors.
New Hill Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
New Hill Management
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
